Preliminary Injunction In 340B Suit Bodes Well For PBMs In Rebate Suit

By John Wilkerson / March 18, 2021 at 6:20 PM

The preliminary injunction in favor of Eli Lilly’s lawsuit against a 340B rule could help pharmaceutical benefit managers in a separate legal challenge to HHS’ Medicare Part D rebate-ban rule.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.